For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.
New synthetic opioids (NSOs) are one of the fastest-growing groups of new psychoactive substances around the world ...
Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if he's confirmed to lead the Department of ...
CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...
A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted all-cause mortality among veterans treated at the VHA.
Fentanyl has emerged as the primary cause of illicit drug deaths in Canada and the United States, and its trafficking has ...
Federal lawmakers are trying once again to push for a study on the “overmedication” of veterans by Department of Veterans ...
Robert F. Kennedy Jr.’s HHS nomination moves to a full Senate vote; Donald Trump’s tariff war sparks China-related concerns for biopharma; Pfizer, Merck and more announce Q4 and 2024 earnings; and the ...
While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...
Vertex Pharmaceuticals ( VRTX 2.53%) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs ...
The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx ...